Beringea related stories
All articles and analysis
- Sustainable Development Capital Gets Strategic Investment
Sustainable Technology Investments Group, the investment manager founded by Gordon Power and Stephen Lansdown, has made a strategic investment in Sustainable Development Capital. Power will join SDC’s board. Specifics of the investment were not publicized.
- Livio Radio Inks Financing from Western Technology
Detroit-based Livio Radio, a manufacturer and developer of car Internet radio products and services, has sealed an undisclosed amount of financing from venture debt provider Western Technology Investment. The terms of the deal were not disclosed. Livio plans to bolster its engineering and marketing efforts. Livio is also backed by Michigan-based venture capital firm Beringea.
- Intervention Insights Closes $7.2M
Grand Rapids, Mich.-based Intervention Insights has closed on $7.2 million in Series B financing. Michigan venture investor Beringea and Louisville, Ky.-based Chrysalis Ventures co-led the round, which also included funding from Hopen Life Sciences, Michigan Accelerator Fund I. The company, a healthcare information technology start-up, will use the money to expand commercialization of its platform, designed to help community oncologists develop individualized patient treatment plans.
- Beringea Exits Steak Group
Media agency network Dentsu has acquired digital marketing services company Steak Group from Farmington Hills, Michigan.-based investment firm Beringea. Terms of the acquisition were not disclosed. Beringea invested in Steak through its London office in 2007 and 2010, the firm said in a written release.
- Beringea Exits Saffron Digital in $48M Deal
The funds ProVen VCT and ProVen Growth & Income VCT, which are managed by venture firm Beringea, have exited their stakes in Saffron Digital, a developer of video delivery platforms, the firm announced. HTC Corp., a designer of smart phones, bought the company for 30 million pounds ($48 million). With the deal, the funds saw a multiple of 5.8 times the cost of the original investment, generating an IRR of 65%.
- Pharma Co. Altacor Closes $3M Tranche
UK-based Altacor, an ophthalmic specialty pharmaceutical company, has closed a 1.9 million pounds ($3 million) second tranche of a total 3.4 million pound ($5.48 million) financing round. NVM Private Equity led the tranche, which included participation from Enterprise Ventures and Beringea. The first tranche closed in the autumn 2010 and was led by Esperante. The Aspire Fund and other unnamed investors also participated.